Multivessel Disease (MVD): 60 Second Insights
Published: 08 March 2018
-
Views:
2254 -
Likes:
7
-
Views:
2254 -
Likes:
7
-
Up Next
-
21sPart 7 | Session 4 Colin Berry
-
32sPart 8 | Session 1 Keith Oldroyd
-
35sPart 8 | Session 2 Simon Walsh
-
39sPart 8 | Session 3 Paul Knaapen
-
8sPart 8 | Session 4 Colin Berry
-
54sPart 9 | Session 1 Keith Oldroyd
-
1m 1sPart 9 | Session 2 Simon Walsh
-
58sPart 9 | Session 3 Paul Knaapen
-
1m 8sPart 9 | Session 4 Colin Berry
-
1m 15sPart 10 | Session 1 Keith Oldroyd
-
52sPart 10 | Session 2 Simon Walsh
-
50sPart 10 | Session 3 Paul Knaapen
-
1m 14sPart 10 | Session 4 Colin Berry
-
43sPart 11 | Session 1 Keith Oldroyd
-
39sPart 11 | Session 2 Simon Walsh
-
57sPart 11 | Session 3 Paul Knaapen
-
19sPart 11 | Session 4 Colin Berry
-
57sPart 1 | Session 1 Keith Oldroyd Keith G Oldroyd
-
1m 7sPart 1 | Session 2 Simon Walsh Simon J Walsh
-
1m 8sPart 1 | Session 3 Paul Knaapen Paul Knaapen
-
53sPart 1 | Session 4 Colin Berry Colin Berry
-
51sPart 2 | Session 1 Keith Oldroyd Keith G Oldroyd
-
57sPart 2 | Session 2 Simon Walsh Simon J Walsh
-
1m 15sPart 2 | Session 3 Paul Knaapen Paul Knaapen
-
1m 10sPart 2 | Session 4 Colin Berry Colin Berry
-
43sPart 3 | Session 1 Keith Oldroyd Keith G Oldroyd
-
1m 14sPart 3 | Session 2 Simon Walsh Simon J Walsh
-
43sPart 3 | Session 3 Paul Knaapen Paul Knaapen
-
45sPart 3 | Session 4 Colin Berry Colin Berry
-
49sPart 4 | Session 1 Keith Oldroyd Keith G Oldroyd
-
1m 4sPart 4 | Session 2 Simon Walsh Simon J Walsh
-
1m 4sPart 4 | Session 3 Paul Knaapen Paul Knaapen
-
1m 12sPart 4 | Session 4 Colin Berry Colin Berry
-
59sPart 5 | Session 1 Keith Oldroyd Keith G Oldroyd
-
1m 7sPart 5 | Session 2 Simon Walsh Simon J Walsh
-
48sPart 5 | Session 3 Paul Knaapen Paul Knaapen
-
42sPart 5 | Session 4 Colin Berry Colin Berry
-
56sPart 6 | Session 1 Keith Oldroyd Keith G Oldroyd
-
1m 5sPart 6 | Session 2 Simon Walsh Simon J Walsh
-
1m 3sPart 6 | Session 3 Paul Knaapen Paul Knaapen
-
49sPart 6 | Session 4 Colin Berry Colin Berry
-
46sPart 7 | Session 1 Keith Oldroyd Keith G Oldroyd
-
52sPart 7 | Session 2 Simon Walsh Simon J Walsh
Overview
A short series of 60-second insight videos on Multivessel Disease (MVD).
More from this programme
Part 1
How do manage patients with multi-vessel disease during PPCI?
Part 2
Do you think we should be doing multi-vessel revascularisation instead of CABG? If so, in which cases?
Part 3
Do you prefer Clopidogrel, Ticagrelor or Prasugrel?
Part 4
Do you have any concerns giving adenosine during PPCI or would your prefer and adenosine-free technique?
Part 5
Do you believe registry (i.e. culprit only) or RCT data (treat all vessels)?
Part 6
Do you believe coronary physiology has a role in non-culprit PPCI decision-making?
Part 7
Are you using G2B3A inhibitors like ReoPro?
Part 8
Are you using Bivalirudin or Heparin?
Part 9
What trials best support the use of MVD PCI?
Part 10
Should we balloon acutely and then returning to stent the following morning?
Part 11
Should PPCI be performed at large surgical centres only?
Faculty Biographies
Paul Knaapen
Interventional Cardiologist and Professor
Personal History
Dr Paul Knaapen is an Interventional Cardiologist, the Director of Cardiac PET/CT and a Professor of Interventional Cardiology at Amsterdam UMC, Netherlands. 4
Academic History
Dr Knaapen received his M.D. from the VU University School of Medicine. He then completed his internship, residency and interventional cardiology fellowship at the VU University Medical Center.5
Career Overview
Dr Knaapen is Professor of Cardiac Intervention and Imaging, Division of Cardiology at the VU University Medical Center, where his major research interest is the clinical value of non‐invasive cardiac imaging, with a particular focus on hybrid PET/CT and chronic total occlusions (CTOs).5
As a clinical researcher, he has co-authored 223 peer-reviewed articles and participated in 7…